18th EURETINA Congress
|
|
- Fay Riley
- 5 years ago
- Views:
Transcription
1 URL: zurück 18th Congress European Society Congress of Retina Specialists 2018 Kongress , 09: , 13: Wien, Österreich Veranstaltungsnummer: Veranstalter: Kurzbeschreibung: The 18th Congress will be held in Vienna, Austria. The scientific program will comprise a variety of symposia, poster sessions, instructional and surgical courses, video and free paper presentations and several satellite meetings. The main topics of this conference are ocular oncology for surgical and medical retina specialists, novelties and late breaking developments in retina and technology, AMD and evidence based treatment in the AntiVEGF Era. Fortbildungspunkte: 27 Fachärzte Gebühren ab: 400,00 EUR EarlyBird bis : 350,00 EUR Member: Before 20 Sept Sept Non-Member: Before 20 Sept Sept Healthcare Professional: Before 20 Sept Sept Ärzte in Weiterbildung Gebühren ab: 240,00 EUR EarlyBird bis : 190,00 EUR Trainee/ Resident Member: Before 20 Sept Sept Trainee/Resident Non-Member: Before 20 Sept Sept medizinisches Fachpersonal Gebühren ab: 200,00 EUR EarlyBird bis : 150,00 EUR
2 Industriemitarbeiter Gebühren ab: 1.500,00 EUR EarlyBird bis : 1.300,00 EUR Bemerkungen: Diese Veranstaltung findet jährlich statt und bietet Fortbildungsmöglichkeiten für Fachärzte, Ärzte in Weiterbildung, medizinisches Fachpersonal und Industriemitarbeiter. Die Zertifizierung wurde von der European Accreditation Council for Continuing Medical Education (EACCME) genehmigt. Sponsoren und Aussteller: Alcon Pharma GmbH Alimera Sciences Ophthalmologie GmbH Bausch + Lomb Bayer HealthCare AG D.O.R.C. Deutschland GmbH (DORC) Ellex Deutschland GmbH Heidelberg Engineering GmbH ifa systems AG MEyeTech GmbH NIDEK Inc. Novartis Pharma GmbH Optos GmbH Deutschland Pharm-Allergan GmbH Quantel Medical Roche Pharma AG Théa Pharma GmbH Topcon ZEISS Vom Veranstalter gemeldetes Programm: Thursday 20th September, 2018 Main Session 1: Ocular Oncology for surgical and medical retina specialists 09:00-10:30 Introduction S. Seregard How modern imaging can aid in the differential diagnosis of small intraocular tumours H. Heimann Intravitreal treatment of radiation - and tumor - associated macular edema L. Zografos How to diagnose intraocular lymphoma - clinical presentation and biopsy techniques N. Bornfeld Surgical resection as an alternative to enucleation in large uveal melanoma - risks and benefits N. Bechrakis Prediction of metastatic disease in patients with uveal melanoma and screening recommendations B. Damato Critical bevaluation of systemic, intracameral and opthalmic artery chemotherapy for retinoblastoma M. Sagoo Main Session 2: The guidelines for management of retinal disease 11:00-12:30 Where is anti-vegf therapy now: achievements and challenges Neovascular AMD: the ten key messages Diabetic macular edema the ten key messages Vein occlusion: the ten key messages A state-of-the-art in endophthalmitis in anti-vegf therapy The future needs and progress in anti-vegf therapy U. Schmidt-Erfurth F. Bandello A. Loewenstein A. Grzybowski D. Martin
3 Main Session 3: Decision making in challenging cases 14:30-16:00 Should we treat subclinical CNV discovered by OCTA? S. Schmitz-Valckenberg Is it valuable to tolerate subretinal fluid in the treatment of type 1 CNV? A. Tufail If a PDR associated with DME is treated by anti-vegf, is it safe to space out injections? Do you stop anti-vegfs in persistent RVO related CME without binocular problems? Should we operate early myopic foveoschisis to avoid complications? Can we expect visual improvement in some lamellar macular hole after surgery? What to do in chronic CSCR when serous retinal detachment reccurs after PDT? How to manage Coat's disease with central macular lipid exudation? R. Silva JR. Vingerling Y. Ikuno R. Schumann C. Boon A. Daruich-Matet Friday 21st September, 2018 Main Session 4: Novelties and late breaking developments in Retina & Technology 8:00-9:30 Recent advances in surgical techniques: new trends and expectations AI-based analysis: A revolution in imaging Genetic therapy: reinventing genes Novel understanding of normal and abnormal retinal vascularization under the light of new imagery Late Breaking Presentations Main Session 5: AMD 12:00-13:30 Dry AMD - how to proceed? Current management of exudative AMD F. Holz New studies in exudative AMD P. Dugel When can we define a patient as a non-responder A. Loewenstein Long-term effects of anti-vegf M. Goldstein Biomarkers on CNV M. Battaglia Parodi Guts, genes and AMD M. Zinkernagel Saturday 22nd September, 2018 Main Session 6:PDR in 2018: Evidence based treatment in the AntiVEGF Era 8:00-9:30 Pathophysiology of macular edema, diabetic and other M. Larsen Retinal photocoagulation : Pro and Cons E. Pilotto Anti VEGF and proliferative diabetic retinopathy trial data: S. Sivaprasad / J. Wells How might Protocol S and Clarity results be generalized in current practice R. Schlingemann Cost effectiveness of antivegf therapy for PDR N. Bressler Vitrectomy in PDR 2018 D. Steel Chaired panel discussion on pragmatic evidence based management of PDR in 2018 (specific scenarios): i. Severe NPDR, treat don t treat? ii. Low risk NVD/E treat don t treat: what with? iii. HRC: no macular edema iv. HRC: with macular edema v. Persistent NV after standard PRP vi. Mild vitreous haemorrhage after full PRP vii. Florid PDR with no previous treatment
4 Main Session 7: Imaging 16:30 Agreement between OCT angiography and FA/ICG in neovascular AMD U. Chakravarthy Single layer OCT, OCT angiography and fuctional correlates in diabetic patients E. Midena Retinal vascular biomakers foralzheimer's disease T. Peto Adaptive optics-slo single photoreceptor imaging and Psychophysics W. Harmening The use of artificial intelligence / deep learning in the analysis of retinal images P. Keane Full volume render virtual reality OCT P. Maloca Main Session 8: Research Session 11:00-12:30 Genetics in retinal disease B. LeRoy Genetics in retinal disease Gene therapy achromatopsia CNGA3 Gene therapy achromatopsia CNGB3 Optogenetics for end-stage retinis pigmentosa (2 perspectives) Cell therapy for age-related macular degeneration Gene therapy for retinis pigmentosa The Argus II retinal implant for retinis pigmentosa The AMS epiretinal implant for retinis pigmentosa C.C.W. Klaver D. Fischer J. Bainbridge S. Kleinlogel R. MacLaren S. Rizzo F. Gekeler Sunday 23 September, 2018 Main Session 9: Vitreoretinal surgery 10:00-11:30 Retinal detachment outcomes in IRIS (Intelligent research in sight) Intraocular foreign body removal: Tips and tricks Paediatric retinal detachment Surgical management of optic pit maculopathy: Which is the best technique? Endoillumination buckle Cold-fusion Retinopathy of prematurity S. Chien Wong J. Garcia Arumi Main Session 10: Myopia - a full update 12:00-13:30 Genetics, risk factors and epidemiology of myopia C.C.W. Klawer Progression of myopia and myopic maculopathy J. Jonas Prevention of myopia and of ist evolution G. Cheung Refractive and lens surgery in highly myopic eyes and lens from the retina perspective Modern imaging of the retina in high myopia Domeshape macula news Myopic choroidal neovascularization management update Update on modern surgery in highly myopic eyes to achieve best possible results New technics for closing myopic macular holes A. Grzybowski Y. lida G. Querques R. Tadayoni M. Figueroa Meet the Experts, OD-OS Navilas Booth C207 Friday, September 21st :00 am - D. Maltsev - Macroaneurysms Saturday, September 22nd :00 am - J. Chhablani - MSP vs. PDT for CSCR 13:30 pm - I. Kozak - Coat's Disease Sunday, September 23rd 2018
5 10:00 am - F. Amorosa - The future of PRP Treatment Veranstaltungsort: Reed Messe Wien Anschrift: Messepl Wien, Österreich Veranstalter: Organisation: Temple House Temple Road, Blackrock Tel.: +353 (0) Fax: +353 (0) Anmeldung: Diese Veranstaltung können Sie derzeit nicht über EYEFOX buchen.
19th ESCRS Winter Meeting
URL: www.eyefox.com/2891 zurück 19th ESCRS Winter Meeting Congress for Ophthalmologists Kongress 20.02.2015, 08:30-22.02.2015, 13:00 34367 Istanbul, Türkei Veranstaltungsnummer: 19120 Veranstalter: Kurzbeschreibung:
More informationAmerican Glaucoma Society 27th Annual Meeting
URL: www.eyefox.com/4762 zurück American Glaucoma Society 27th Annual Meeting AGS 2017 Symposium 02.03.2017, 14:00-05.03.2017, 11:00 CA 92118 Coronado, USA Veranstaltungsnummer: 19808 Veranstalter: American
More informationXXXI Congress of the ESCRS
URL: www.eyefox.com/965 zurück XXXI Congress of the ESCRS European Society of Cataract and Refractive Surgeons Kongress 05.10.2013, 08:30-09.10.2013, 13:00 1078 GZ Amsterdam, Niederlande Veranstaltungsnummer:
More information7th World Congress on Controversies in Ophthalmology (COPHy)
URL: www.eyefox.com/3503 zurück 7th World Congress on Controversies in Ophthalmology (COPHy) COPHy Congress 2016 Kongress 31.03.2016, 19:00-02.04.2016, 17:00 00-844 Warsaw, Polen Veranstaltungsnummer:
More informationURL: zurück
URL: www.eyefox.com/471 zurück EVER 2012 Sience for Sight Fortbildung 10.10.2012, 12:00-13.10.2012, 19:30 06300 Nizza, Frankreich Veranstaltungsnummer: 10410 Veranstalter: EVER Office - European Association
More informationXXIV SIDUO 2012 Congress
URL: www.eyefox.com/572 zurück XXIV SIDUO 2012 Congress Weltkongress der Ultraschallvereinigung in der Augenheilkunde 08.12.2012, 08:45-11.12.2012, 17:50 01419-002 São Paulo, Brasilien Veranstaltungsnummer:
More information2nd Trends in Glaucoma
URL: www.eyefox.com/5729 zurück 2nd Trends in Glaucoma International Meeting on New Imaging Technologies, Lasers and Glaucoma Surgery Symposium 18.11.2016, 09:00-19.11.2016, 13:00 08035 Barcelona, Spanien
More informationTeaching course: Diagnostic Ophthalmic Ultrasound
URL: www.eyefox.com/4787 zurück Teaching course: Diagnostic Ophthalmic Ultrasound Annual Course and Workshop, Basic and Advanced Lehrkurs 01.02.2016, 08:00-05.02.2016, 19:00 80138 Naples, Italien Veranstaltungsnummer:
More informationURL: zurück
URL: www.eyefox.com/83 zurück 12th EVRS Meeting Macular edemas. Medical vs surgical retina: new frontiers Kongress 15.09.2012, 09:00-18.09.2012, 13:20 01067 Dresden, Sachsen, Deutschland Veranstaltungsnummer:
More informationAPRIL 8th 2016 Therapy
APRIL 8th 2016 Therapy 09.00-10.00 SESSION 1: Age-related Macular Degeneration Moderators: A. Brucker, E. Souied, M. Stirpe, R. Brancato 09.00-09.15 TBD A. Brucker 09.15-09.30 TBD E. Souied 09.30-09.45
More informationAPRIL 8th 2016 Therapy
APRIL 8th 2016 Therapy 09.00-10.00 SESSION 1: Age-related Macular Degeneration Moderators: A. Brucker, E. Souied, M. Stirpe, F. Boscia 09.00-09.15 TBD A. Brucker 09.15-09.30 Anti-PDGF and CNV fibrosis
More informationAECOS Summer Symposium 2018
URL: www.eyefox.com/8390 zurück AECOS Summer Symposium 2018 Symposium 12.07.2018, 13:00-15.07.2018, 12:30 UT 84060 Park City, USA Veranstaltungsnummer: 25842 Veranstalter: Kurzbeschreibung: The welcomes
More informationFINAL PROGRAM TRENDS IN SURGICAL III. Borja Corcóstegui, MD IMO - Barcelona May 29th & 30th 2015, Barcelona
FINAL PROGRAM III TRENDS IN SURGICAL & MEDICAL RETINA Live Surgery and Round Tables Borja Corcóstegui, MD IMO - Barcelona May 29th & 30th 2015, Barcelona Join the IMO team and eminent guest surgeons in
More informationAdvanced Vitreoretinal Techniques & Technology Symposium
14th ANNUAL Advanced Vitreoretinal Techniques & Technology Symposium JULY 25-27, 2014 SWISSÔTEL CHICAGO CHICAGO, IL CME ACCREDITATION AND CREDIT STATEMENT This activity has been planned and implemented
More informationSCIENTIFIC PROGRAM. Monday, June 13, :00 19:00 Registration 00:00 20:00 Reception Cocktail Tuesday, June 14, 2016
Monday, June 13, 2016 18:00 19:00 Registration 00:00 20:00 Reception Cocktail Tuesday, June 14, 2016 08:30 09:00 Registration Moderator: V. Ferrara 09:00 09:30 Primary Vitrectomy and GAS Fluid exchange,
More informationBarcelona, 3 4 June 2011 Auditorium IMO (Institut de Microcirurgia Ocular)
Trends in Surgical and Medical Retina Barcelona, 3 4 June 2011 Auditorium IMO (Institut de Microcirurgia Ocular) www.esaso.ch 1 Trends in Surgical and Medical Retina Trends in Surgical and Medical Retina
More informationAdvanced Vitreoretinal Techniques & Technology Symposium
15th ANNUAL Advanced Vitreoretinal Techniques & Technology Symposium AUGUST 28-30, 2015 SWISSÔTEL CHICAGO CHICAGO, IL CME ACCREDITATION AND CREDIT DESIGNATION This activity has been planned and implemented
More informationFrankfurt Retina Meeting
P r e l i m i n a r y P r o g r a m 2 Frankfurt Retina Meeting Live Surgery Video Presentations Lectures MARCH 24 th - 25 th 2018 Faculty as of December 2017 Remzi Avci David Chow Donald D Amico Morten
More informationOCT Interpretation in Retinal Disease
OCT Interpretation in Retinal Disease Jay M. Haynie, OD, FAAO Financial Disclosure I have received honoraria or am on the advisory board for the following companies: Carl Zeiss Meditec Advanced Ocular
More informationAdvanced Vitreoretinal Techniques
AUGUST 25-27, 2017 PALMER HOUSE HILTON CHICAGO, IL 18th ANNUAL Advanced Vitreoretinal Techniques & Technology Symposium This activity has been planned and implemented in accordance with the accreditation
More information15th EVRS Meeting 2015
URL: www.eyefox.com/4808 zurück 15th EVRS Meeting 2015 European Vitreoretinal Society Meeting Kongress 12.09.2015, 13:30-14.09.2015, 19:30 30125 Venice, Italien Veranstaltungsnummer: 19817 Veranstalter:
More informationURL: zurück
URL: www.eyefox.com/469 zurück 31st ESOPRS Annual Meeting of the European Society of Ophthalmic Plastic and Reconstructive Surgery Kongress 12.09.2012, 08:15-15.09.2012, 14:30 10111 Tallinn, Estland Veranstaltungsnummer:
More informationAPRIL 11 th, Milan, NH Milano 2. CHAIRMAN Francesco Bandello, MD, FEBO
APRIL 11 th, 2015 Milan, NH Milano 2 CHAIRMAN Francesco Bandello, MD, FEBO www.octforum2015.eu Welcome It is an honor for us to welcome you to 1 st San Raffaele OCT Forum. It is our intention to make this
More informationJANUARY 27-29, TH ANNUAL Retina Fellows Forum. Westin Chicago River North Chicago, IL
17TH ANNUAL Retina Fellows Forum JANUARY 27-29, 2017 Westin Chicago River North Chicago, IL Course Director: Course Co-Directors: and David R. Chow, MD Faculty Course Co-Director Tennessee Retina Nashville
More informationThe Human Eye. Cornea Iris. Pupil. Lens. Retina
The Retina Thin layer of light-sensitive tissue at the back of the eye (the film of the camera). Light rays are focused on the retina then transmitted to the brain. The macula is the very small area in
More informationFRANZCO, MD, MBBS. Royal Darwin Hospital
Diabetes and Eye By Dr. Nishantha Wijesinghe FRANZCO, MD, MBBS Consultant Ophthalmologist Royal Darwin Hospital 98% of Diabetics do not need to suffer from severe visual loss Yet Diabetic eye disease is
More informationThe Wilmer Eye Institute s 34 th Annual Current Concepts in Ophthalmology March 13-17, 2017 Vail Marriott * Vail, Colorado
The Wilmer Eye Institute s 34 th Annual Current Concepts in Ophthalmology March 13-17, 2017 Vail Marriott * Vail, Colorado Tentative 1/23/17 PROGRAM MONDAY, MARCH 13, 2017 Morning Session 6:00-7:00 Registration
More informationWhen to Refer to RETINA. Joseph M. Coney, MD February 17, 2017 Memphis, TN
When to Refer to RETINA Joseph M. Coney, MD February 17, 2017 Memphis, TN Financial Disclosure Commercial Interest What was received For what role Aerpio Grant Support Contracted Research Alcon Laboratories
More informationSCIENTIFIC PROGRAM. Pediatric ophthalmology- Optometry challenges (max 20 attendees)
FRIDAY, 22 SEPTEMBER 2017 WORKSHOPS (OPHTHALMICA Eye Institute) 08:30-09:00 Registration-Welcome 09:00-11:30 Workshops SCIENTIFIC PROGRAM I. Cornea & Refractive surgery (max 30 attendees) - Clinical examination
More informationDiagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City
Diagnosis and treatment of diabetic retinopathy Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City Disclosures Consulted for Novo Nordisk 2017,2018. Will be discussing
More informationCENTENE PHARMACY AND THERAPEUTICS NEW DRUG REVIEW 2Q17 April May
BRAND NAME Lucentis GENERIC NAME ranibizumab MANUFACTURER Genentech, Inc. DATE OF APPROVAL June 30, 2006 PRODUCT LAUNCH DATE July 13, 2006 REVIEW TYPE Review type 1 (RT1): New Drug Review Full review of
More informationThe Wilmer Eye Institute s 34 th Annual Current Concepts in Ophthalmology March 13-17, 2017 Vail Marriott * Vail, Colorado
The Wilmer Eye Institute s 34 th Annual Current Concepts in Ophthalmology March 13-17, 2017 Vail Marriott * Vail, Colorado PROGRAM SUNDAY, MARCH 12, 2017 3:30 5:30 Early Registration MONDAY, MARCH 13,
More informationPosterior Segment Update
Posterior Segment Update Featured Speaker: Dr. Kyle Cheatham, FAAO, DIP ABO DISCLOSURE STATEMENT We have no direct financial or proprietary interest in any companies, products or services mentioned in
More informationOCT Angiography in Primary Eye Care
OCT Angiography in Primary Eye Care An Image Interpretation Primer Julie Rodman, OD, MS, FAAO and Nadia Waheed, MD, MPH Table of Contents Diabetic Retinopathy 3-6 Choroidal Neovascularization 7-9 Central
More informationContents. Chapter 1 Common Pitfalls in the Use of Optical Coherence Tomography for Macular Diseases Lihteh Wu and Teodoro Evans
Contents Chapter 1 Common Pitfalls in the Use of Optical Coherence Tomography for Macular Diseases Lihteh Wu and Teodoro Evans 1.1 Introduction... 1 1.2 Limitations of Time-Domain OCT... 2 1.2.1 Acquisition
More informationThe College of Optometrists - Learning outcomes for the Professional Certificate in Medical Retina
Learning outcomes for the Professional Certificate in Medical Retina, incorporating diabetic retinopathy screening and age related macular degeneration The professional certificate is a prerequisite to
More informationOCT Interpretation. Financial Disclosure. Jay M. Haynie, OD, FAAO. OCT Image Layers 7/21/2014
OCT Interpretation Jay M. Haynie, OD, FAAO Financial Disclosure I have received honoraria or am on the advisory board for the following companies: Olympia Tacoma Renton Kennewick - Washington Carl Zeiss
More informationOptical Coherence Tomography: Pearls for the Anterior Segment Surgeon Basic Science Michael Stewart, M.D.
Optical Coherence Tomography: Pearls for the Anterior Segment Surgeon Basic Science Michael Stewart, M.D. Disclosure OCT Optical Coherence Tomography No relevant financial relationships I will refer to
More informationWhat Is O.C.T. and Why Should I Give A Rip? OCT & Me How Optical Coherence Tomography Changed the Life of a Small Town Optometrist 5/19/2014
OCT & Me How Optical Coherence Tomography Changed the Life of a Small Town Optometrist Email: myoder@wcoil.com Mark A. Yoder, O.D. 107 N. Main Street PO Box 123 Bluffton, OH 45817 @yoderod 115.02 Histoplasma
More informationWhen optical coherence tomography (OCT)
Macular Imaging: SD-OCT in nterior Segment Surgical Practice Many pathologic processes of the macula can be visualized or quantified only with this modality. y Steven G. Safran, MD When optical coherence
More informationOffice Based Practice. Vitreoretinal Disease & Surgery. Coding Fiesta Vitreoretinal Disease & Surgery September 23, 2017 ADULT RETINA
Vitreoretinal Disease & Surgery Coding Fest 2017 Vitreoretinal Surgery & Disease University of FL College of Medicine ADULT RETINA Medical Retina Surgical Retina Age Related Vascular Disease Vascular Disease
More informationPoster Viewing Transcript Saturday, June 2
Viewing Transcript Saturday, June 2 Name: Royal College ID #: In order to claim your credits, please record them in your MAINPORT eportfolio using the Bulk online reading/scanning with transcript option
More informationSURGICAL VITREORETINAL FELLOWSHIP PROGRAM. UNIVERSITY OF KENTUCKY AND RETINA ASSOCIATES OF KENTUCKY Lexington, Kentucky
SURGICAL VITREORETINAL FELLOWSHIP PROGRAM UNIVERSITY OF KENTUCKY AND RETINA ASSOCIATES OF KENTUCKY Lexington, Kentucky UK Fellowship Director P. Andrew Pearson, M.D. UK Vitreoretinal Faculty Romulo Albuquerque,
More informationRetinal Diseases. Age-Related Macular Degeneration. What Is AMD? Risk Factors for AMD
Santosh C. Patel, M.D. Retina Specialists The Latest And Greatest in the Management of Retinal Diseases February 13, 2007 Retinal Diseases Majority of Blindness in Civilized World AMD Diabetic Retinopathy
More information8th HIPPOCRATIC MEETING 27&28 MARCH 2015 RETINA MACULA VITREOUS MAKEDONIA PALACE / THESSALONIKI
1 ND AND 2 ND DEPARTMENTS OF OPHTHALMOLOGY, ARISTOTLE UNIVERSITY OF THESSALONIKI 2 ND DEPARTMENT OF OPHTHALMOLOGY, UNIVERSITY OF ATHENS DEPARTMENT OF OPHTHALMOLOGY, UNIVERSITY OF THESSALY in cooperation
More informationAngio-OCT. Degenerazione Maculare Legata all Eta. Giuseppe Querques
Angio-OCT Degenerazione Maculare Legata all Eta Giuseppe Querques Department of Ophthalmology, IRCCS Ospedale San Raffaele, University Vita Salute San Raffaele, Milan, Italy Financial Disclosure ADVISORY
More informationPART 1: GENERAL RETINAL ANATOMY
PART 1: GENERAL RETINAL ANATOMY General Anatomy At Ora Serrata At Optic Nerve Head Fundoscopic View Of Normal Retina What Is So Special About Diabetic Retinopathy? The WHO definition of blindness is
More informationOCT Angiography The Next Frontier
Choroid Retina avascular 5/13/2017 OCT Angiography The Next Frontier Pierce Kenworthy OD, FAAO June 9, 2017 OCT Angiography (OCTA) 2016 Non-invasive, motion contrast imaging Represents erythrocyte movement
More informationCourse # Getting to Know Your OCT
Course # 140 Getting to Know Your OCT Course Title: Lecturer: Getting to Know Your OCT Brad Sutton, OD, FAAO IU School of Optometry Financial Disclosures No financial disclosures Optical Coherence Tomography-OCT
More informationRetinal Complications of Obstructive Sleep Apnea A Growing Concern!
Retinal Complications of Obstructive Sleep Apnea A Growing Concern! Jay M. Haynie, OD, FAAO Financial Disclosure I have received honoraria or am on the advisory board for the following companies: Carl
More informationOphthalmology Macular Pathways
Ophthalmology Macular Pathways Age related Macular Degeneration Diabetic Macular Oedema Macular Oedema secondary to Central Retinal Macular Oedema secondary to Branch Retinal CNV associated with pathological
More informationDarren J. Bell, M.D. Texas A&M University College of Medicine College Station, Texas Doctor of Medicine
Darren J. Bell, M.D. Education Texas A&M University College of Medicine College Station, Texas Doctor of Medicine 1997-2001 Texas A&M University College Station, Texas Bachelor of Science, Biomedical Engineering
More informationCentral venous occlusion
Central venous occlusion Central venous occlusion (right eye) There are dark haemorrhages at the macula and all over the retina. Choroidal haemangioma A choroidal haemangioma has salmon pink colour. There
More informationEFFICACY OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS IN RETINAL DISORDER FOR BETTER VISUAL ACUITY
EFFICACY OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS IN RETINAL DISORDER FOR BETTER VISUAL ACUITY Diwakar chaudhary *1, 2, Hu shuqiong, Long Yuan and Xiong kun 1 Yangtze University, 1 Nanhuan Road
More informationDiabetic Retinopatathy
Diabetic Retinopatathy Jay M. Haynie, OD, FAAO Financial Disclosure I have received honoraria or am on the advisory board for the following companies: Carl Zeiss Meditec Arctic DX Macula Risk Advanced
More informationOphthalmic VEGF Inhibitors. Eylea (aflibercept), Macugen (pegaptanib) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Ophthalmic VEGF Inhibitors Page: 1 of 5 Last Review Date: September 20, 2018 Ophthalmic VEGF Inhibitors
More informationPublished on Points de Vue International Review of Ophthalmic Optics (http://www.pointsdevue.com)
Published on Points de Vue International Review of Ophthalmic Optics (http://www.pointsdevue.com) Home > OCT and retinal pathologies OCT and retinal pathologies Sylvain AURIOL, Véronique PAGOT-MATHIS e-mail
More informationVenturi versus peristaltic pumps 33 vitrectomy dynamics 34 Fluorescein, vitreous staining 120
Subject Index Accurus 35, 83 Aflibercept, diabetic macular edema management 167, 168 Air-forced infusion, Stellaris PC 12, 13 Alcon Constellation, see Constellation system Autoclave sterilization lens
More informationPhotodynamic Therapy (PDT) for agerelated
Page 1 of 5 Photodynamic Therapy (PDT) for agerelated eye conditions Introduction This leaflet gives you information about Photodynamic Therapy (PDT) for the age--related eye conditions macular degeneration
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article A Multivariate Analysis of Intravitreal Injection of Anti-VEGF Bevacizumab in the Treatment
More informationA Review of Subthreshold Micropulse Laser and Recent Advances in Retinal Laser Technology
Ophthalmol Ther (2017) 6:1 6 DOI 10.1007/s40123-017-0077-7 REVIEW A Review of Subthreshold Micropulse Laser and Recent Advances in Retinal Laser Technology Daniel Su. Jean-Pierre Hubschman Received: December
More informationmeasure of your overall performance. An isolated glucose test is helpful to let you know what your sugar level is at one moment, but it doesn t tell you whether or not your diabetes is under adequate control
More informationIntravitreal bevacizumab for pediatric exudative retinal diseases
Saudi Journal of Ophthalmology (2011) 25, 193 197 King Saud University Saudi Journal of Ophthalmology www.saudiophthaljournal.com www.ksu.edu.sa www.sciencedirect.com ORIGINAL ARTICLE Intravitreal bevacizumab
More informationVitreoretinal surgical management In ocular oncology
www.ophtalmique.ch Vitreoretinal surgical management In ocular oncology Pournaras Jean-Antoine C Vitreoretinal Surgery Unit 1. Surgical resection after proton beam therapy 2. Ocular Biopsy 3. RD in advanced
More informationOPHTHALMOLOGIC POLICY: VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITORS
UnitedHealthcare Commercial Medical Benefit Drug Policy OPHTHALMOLOGIC POLICY: VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITORS Policy Number: PHA020 Effective Date: September 1, 2018 Table of Contents
More informationClinical Case Presentation. Branch Retinal Vein Occlusion. Sarita M. Registered Nurse Whangarei Base Hospital
Clinical Case Presentation on Branch Retinal Vein Occlusion Sarita M. Registered Nurse Whangarei Base Hospital Introduction Case Study Pathogenesis Clinical Features Investigations Treatment Follow-up
More informationOphthalmology. Juliette Stenz, MD
Ophthalmology Juliette Stenz, MD Required Slide Disclosures NO SIGNIFICANT FINANCIAL, GENERAL, OR OBLIGATION INTERESTS TO REPORT Required Slide At the end of this session, students will be able to: 1.
More informationNavilas Clinical Results: Diabetic Macular Edema Introducing a Better Treatment Paradigm for Patients and Physicians
Navilas Clinical Results: Diabetic Macular Edema Introducing a Better Treatment Paradigm for Patients and Physicians 16 % Injection-free after loading phase 65 % Injection-free after loading phase Navilas
More informationRoyal Berkshire Hospital Dunedin Hospital. Prince Charles Eye Unit Pi Princess Margaret Hospital
Vitreoretinal Surgery Mr Vaughan Tanner www.tanner-eyes.co.uk eyes Reading Royal Berkshire Hospital Dunedin Hospital Windsor Prince Charles Eye Unit Pi Princess Margaret Hospital Success rates VR surgery
More informationIncorporating OCT Angiography Into Patient Care
Incorporating OCT Angiography Into Patient Care Beth A. Steele, OD, FAAO OCT A: Introduction Isolates microvascular circulation from OCT image data Axial resolution = 5 microns (i.e. fine capillaries visible)
More informationThe Quick Guide to OCT Mastery 50 Real Cases with Expert Analysis
OPTICAL COHERENCE TOMOGRAPHY The Quick Guide to OCT Mastery 50 Real Cases with Expert Analysis VOL 1 Sanjay Sharma, MD, FRCS, MSc (Epid), MBA Ophthalmologist, Epidemiologist Queen s University, Canada
More informationDiabetic Retinopathy
Diabetic Retinopathy Diabetes can be classified into type 1 diabetes mellitus and type 2 diabetes mellitus, formerly known as insulin-dependent diabetes mellitus, and non-insulin diabetes mellitus, respectively.
More informationVanderbilt Eye Institute Clinical Trials
April, 2010 Vanderbilt Eye Institute Clinical Trials Ophthalmology Actively Recruiting Studies For information on our clinical trials and other studies, please contact: Sandy Owings, COA, CCRP Clinic Director
More informationIs OCT-A Needed As An Investigative Tool During The Management Of Diabetic Macular Edema
Is OCT-A Needed As An Investigative Tool During The Management Of Diabetic Macular Edema Ayman M Khattab MD, FRCS Professor of Ophthalmology Cairo University Diabetic Macular Edema (DME) Diabetic macular
More informationWorld Sight Day Case Studies. Mark Frost Screening Manager South East London DESP
World Sight Day 2015 Case Studies Mark Frost Screening Manager South East London DESP Introduction All of the following cases have been identified in our screening programme over the last 3 years. The
More informationPractical Care of the Cataract Patient with Retinal Disease
Practical Care of the Cataract Patient with Retinal Disease Brooks R. Alldredge, OD, FAAO Kelly L. Cyr, OD, FAAO The Retina Center Eye Associates of New Mexico 4411 The 25 Way NE, Suite 325 Albuquerque,
More informationReviewing Codes 1200 accommodation and presbyopia, in vivo and in vitro - VI 1210 adaptive optics: imaging science - VI 1220 adaptive optics:
2018 - Reviewing Codes 1200 accommodation and presbyopia, in vivo and in vitro - VI 1210 adaptive optics: imaging science - VI 1220 adaptive optics: visual function and performance - VI 1230 allergic conjunctivitis
More informationIntraocular Radiation Therapy for Age-Related Macular Degeneration
Medical Policy Manual Medicine, Policy No. 134 Intraocular Radiation Therapy for Age-Related Macular Degeneration Next Review: April 2019 Last Review: June 2018 Effective: August 1, 2018 IMPORTANT REMINDER
More informationDr Mallika Goyal, MD, DNBE
Dr Mallika Goyal, MD, DNBE Address Ophthalmology Department International Pavilion Apollo Health City Near Check Post Jubilee Hills, Hyderabad 500 033 Telephone +91-40-23554563 (office) Mobile: +91-9849270994
More informationMark Dunbar: Disclosure
Important Things to Understand About OCT Mark T. Dunbar, O.D., F.A.A.O. Bascom Palmer Eye Institute University of Miami, School of Medicine Mark Dunbar: Disclosure Optometry Advisory Board for: Allergan
More information04/06/2015. Documentation Do s and Don ts In The Retina Practice. Financial Disclosure. Documentation Dos and Don ts
Documentation Do s and Don ts In The Retina Practice William T. Koch, COA, COE, CPC Administrative Director Director of Billing Operations The Retina Institute St. Louis, Missouri Advisory Boards Allergan
More informationCorinne GONZALEZ Ophthalmology (MD, Ph.D ) Retinal Medical Specialist
Corinne GONZALEZ Ophthalmology (MD, Ph.D ) Retinal Medical Specialist PRESENT PROFESSIONAL POSITION OPHTALMOLOGIST DOCTOR, Private practice Retinal medical Specialist, DMLA in particular Installation year
More informationOishi A, Miyamoto K, Yoshimura N. Etiology of carotid cavernous fistula in Japanese. Jpn J Ophthalmol. 2009;53:40-43.
Kimura T, Takagi H, Miyamoto K, Kita M, Watanabe D, Yoshimura N. Macular hole with epiretinal membrane after triamcinolone-assisted vitrectomy for proliferative diabetic retinopathy. Retinal Cases Brief
More informationClinical Outcomes After Intravitreal Bevacizumab Injection for Diabetic Macular Edema
Original Article Clinical Outcomes After Intravitreal Bevacizumab Injection for Diabetic Macular Edema Karen Joyce G. Castro, MD, Marie Joan V. Loy, MD International Eye Institute St. Luke s Medical Center
More informationRetina Conference. Janelle Fassbender, MD, PhD University of Louisville Department of Ophthalmology and Visual Sciences 09/04/2014
Retina Conference Janelle Fassbender, MD, PhD University of Louisville Department of Ophthalmology and Visual Sciences 09/04/2014 Subjective CC/HPI: 64 year old Caucasian female referred by outside ophthalmologist
More informationFront Line Diabetic Retinopathy What Not to Miss and Why
Front Line Diabetic Retinopathy What Not to Miss and Why David M Brown MD FACS Clinical Professor of Ophthalmology Blanton Eye Institute, Houston Methodist Hospital Baylor College of Medicine Retina Consultants
More informationRS-3000 Advance Clinical Library Courtesy Of Kittner Eye Center UNC
RS-3000 Advance Clinical Library Courtesy Of Kittner Eye Center UNC Info We would like to first thank our friends at Kittner Eye Center at UNC for providing us with these amazing images taken on the NIDEK
More informationBrazil Emmett T. Cunningham, Jr., M.D., Ph.D., M.P.H. United States Christine Curcio, M.D. United States Amani Fawzi, M.D. Japan Michael Larsen, M.D.
COURSE DIRECTORS K. Bailey Freund, M.D. David Sarraf, M.D. CO-DIRECTORS SriniVas Sadda, M.D. Richard F. Spaide, M.D. Lawrence A. Yannuzzi, M.D. FACULTY Anita Agarwal, M.D. Francesco Bandello, M.D. Italy
More informationOPTIC DISC PIT Pathogenesis and Management OPTIC DISC PIT
OPTIC DISC PIT Pathogenesis and Management Abdel-Latif Siam Ain Shams University Cairo Egypt OPTIC DISC PIT Congenital pit is an atypical coloboma usually located on the temporal edge of the disc, associated
More informationClinically Significant Macular Edema (CSME)
Clinically Significant Macular Edema (CSME) 1 Clinically Significant Macular Edema (CSME) Sadrina T. Shaw OMT I Student July 26, 2014 Advisor: Dr. Uwaydat Clinically Significant Macular Edema (CSME) 2
More information04/11/2014. Retina Coding and Reimbursement 101. Financial Disclosure. Chief Complaint
Retina Coding and Reimbursement 101 William T. Koch, COA, COE, CPC Administrative Director Director of Billing Operations The Retina Institute St. Louis, Missouri Advisory Boards Allergan Genentech Regeneron
More informationThe Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care
The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care Medical Retina November 2016 Association of Health Professions in Ophthalmology General basic
More informationComparison of BRVO and CRVO management
Comparison of BRVO and CRVO management Francesco Bandello, MD, FEBO Department of Ophthalmology University Vita-Salute Scientific Institute San Raffaele Milan, Italy 1 Financial Disclosure Advisory Board
More informationSwept-Source Optical Coherence Tomography
Swept-Source Optical Coherence Tomography A Color Atlas This page intentionally left blank Swept-Source Optical Coherence Tomography A Color Atlas Kelvin Y.C. Teo Wong Chee Wai Andrew S.H. Tsai Daniel
More informationSince /01/2014 Private practice Ophthalmology, Retinal Medical Specialty and AMD, private office
Corinne GONZALEZ Ophthalmology (MD, Ph.D ) Retinal Medical Specialist SELARL CABINET DOCTEUR GONZALEZ 27, Boulevard des Minimes 31 200 Toulouse! 05 34 40 77 30 e-mail : cabinet.dr.gonzalez@wanadoo.fr Fax
More informationOphthalmologic Policy. Vascular Endothelial Growth Factor (VEGF) Inhibitors
Ophthalmologic Policy UnitedHealthcare Commercial Drug Policy Vascular Endothelial Growth Factor (VEGF) Inhibitors Policy Number: 2016D0042H Effective Date: October 1, 2016 Table of Contents Page INSTRUCTIONS
More informationDiabetic Retinopathy
Diabetic Retinopathy Diabetes mellitus is one of the leading causes of irreversible blindness worldwide. In the United States, it is the most common cause of blindness in people younger than 65 years.
More informationCENTRAL MERSEY LOCAL OPTICAL COMMITTEE
CENTRAL MERSEY LOCAL OPTICAL COMMITTEE OPTOMETRIC REFERRAL GUIDELINES The ocular conditions listed in this document are intended to reflect those that might be encountered in optometric practice and this
More informationSUMMARY. Heather Casparis, MD,* and Neil M. Bressler, MD MARINA AND ANCHOR
The following are summaries of selected presentations and posters from the American Society of Retina Specialists and European VitreoRetinal Society Annual Meeting held September 9 13, 2006, in Cannes,
More information